Inventor · disambiguated record
Benjamin M. Cohen
Also filed as: COHEN BENJAMIN · COHEN BENJAMIN M · COHEN BENJAMIN MAX
29 granted patents·6 pending applications·99 citations·filing 2006–2025
96Inventor score
Files withCELGENE CORP18BRISTOL MYERS SQUIBB CO6SIGNAL PHARM LLC3WONG JEANNIE CHOW3VIIV HEALTHCARE UK NO 4 LTD2
Top patents by PatentIndex Score
35 records- 0195US9221788B2Salts and solid forms of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2013·Granted Dec 29, 2015·21 cites·77 claims
- 0293US8802685B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesMULLER GEORGE·Filed 2012·Granted Aug 12, 2014·9 cites·61 claims
- 0392US9359364B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2014·Granted Jun 7, 2016·10 cites·28 claims
- 0491US12343346B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2024·Granted Jul 1, 2025·0 cites·7 claims
- 0591US9629849B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2015·Granted Apr 25, 2017·7 cites·41 claims
- 0691US9067912B2Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,8-dioneCELGENE CORP·Filed 2014·Granted Jun 30, 2015·5 cites·42 claims
- 0789US9309220B2Processes for the preparation of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereofCELGENE CORP·Filed 2013·Granted Apr 12, 2016·14 cites·34 claims
- 0888US9403829B2Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their useSIGNAL PHARM LLC·Filed 2012·Granted Aug 2, 2016·13 cites·29 claims
- 0987US9751853B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2015·Granted Sep 5, 2017·4 cites·10 claims
- 1087US9249121B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2014·Granted Feb 2, 2016·2 cites·53 claims
- 1187US2025281501A1Salts and solid forms of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2025·Application pending·0 cites
- 1286US9969713B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2017·Granted May 15, 2018·1 cites·15 claims
- 1384US10463672B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2017·Granted Nov 5, 2019·2 cites·13 claims
- 1483US9884062B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2017·Granted Feb 6, 2018·2 cites·34 claims
- 1580US2022125797A1Salts and solid forms of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2022·Application pending·0 cites
- 1678US9975872B2Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereofCELGENE CORP·Filed 2016·Granted May 22, 2018·2 cites·12 claims
- 1775US9303014B2Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dioneCELGENE CORP·Filed 2015·Granted Apr 5, 2016·1 cites·3 claims
- 1874US11241439B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2020·Granted Feb 8, 2022·0 cites·12 claims
- 1974US9266858B2Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dioneCELGENE CORP·Filed 2015·Granted Feb 23, 2016·1 cites·24 claims
- 2072US12269840B2Process for the preparation of a cyclic dinucleotideBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 8, 2025·1 cites·17 claims
- 2172US10596180B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl) oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2019·Granted Mar 24, 2020·0 cites·14 claims
- 2272US2022127233A1Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparationBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2371US8093295B2Formulations of suberoylanilide hydroxamic acid and methods for producing the sameWONG JEANNIE CHOW·Filed 2006·Granted Jan 10, 2012·2 cites·68 claims
- 2470US11919863B2Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparationBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Mar 5, 2024·0 cites·17 claims
- 2569US8450372B2Formulations of suberoylanilide hydroxamic acid and methods for producing sameWONG JEANNIE CHOW·Filed 2010·Granted May 28, 2013·2 cites·61 claims
- 2666US2018305333A1Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2018·Application pending·0 cites
- 2764US9827243B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2016·Granted Nov 28, 2017·0 cites·17 claims
- 2864US2025197440A1Process for the preparation of a cyclic dinucleotideBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 2961US11236048B2Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparationBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 1, 2022·0 cites·16 claims
- 3050US8232413B2Process for the production of a crystalline glucagon receptor antagonist compoundCOHEN BENJAMIN M·Filed 2008·Granted Jul 31, 2012·0 cites·14 claims
- 3145US8288440B2Formulations of suberoylanilide hydroxamic acid and methods for producing sameWONG JEANNIE CHOW·Filed 2010·Granted Oct 16, 2012·0 cites·24 claims
- 3243US9518058B2Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamideBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Dec 13, 2016·0 cites·9 claims
- 3337US8796452B2Preparation of lamivudine form ICOHEN BENJAMIN·Filed 2011·Granted Aug 5, 2014·0 cites·25 claims
- 3431US9908882B2Process for preparing halogenated azaindole compounds using boroxineVIIV HEALTHCARE UK NO 4 LTD·Filed 2015·Granted Mar 6, 2018·0 cites·2 claims
- 3530US2017362262A1A process for preparing halogenated azaindole compounds using pybropVIIV HEALTHCARE UK (NO 4) LTD·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →